What is the Iran nuclear deal? European Union High Representative for Foreign Affairs and Security Policy Federica Mogherini, Iranian Foreign Minister Mohammad Javad Zarif, British Foreign Secretary Philip Hammond and Secretary of State John Kerry stand together in July 2015. The agreement was aimed at ensuring that Tehran's nuclear program "will be exclusively peaceful" in return for the lifting of sanctions. Apr.25.2018 [...] Who signed it? Iran signed the agreement with the five permanent members of the U.N. Security Council — the U.S., Russia, France, China and the United Kingdom — as well as Germany and the European Union. [...] https://www.nbcnews.com/storyline/smart-facts/what-iran-nuclear-deal-n868346 [with embedded videos]
6 questions about the Iran deal you were too embarrassed to ask Former US Secretary of State John Kerry and current Iranian Foreign Minister Mohammad Javad Zarif both negotiated the Iran nuclear deal. Trump seems poised to remove the US from the deal on Tuesday, May 8, 2018. President Trump has withdrawn the US from the Iran nuclear deal. Here’s what you need to know. Updated May 8, 2018 [...] 1) What does the Iran deal do? Simply put, the nuclear deal, known formally as the Joint Comprehensive Plan of Action, stops Iran from getting a nuclear weapon for at least a decade. On July 14, 2015, a group of countries — the United States, the United Kingdom, France, Russia, China, Germany, and the European Union — agreed to lift crippling sanctions imposed on Iran’s nuclear program, giving it greater access to the global economy. In return, Iran agreed to take concrete steps to curb its nuclear program, limiting it to strictly peaceful applications, and to allow comprehensive inspections of key nuclear facilities by the International Atomic Energy Agency (IAEA) to ensure compliance. [...] https://www.vox.com/2018/5/8/17319608/trump-iran-nuclear-deal-announcement-explained
DEAL OR NO DEAL What does the Iran nuclear deal entail, which countries signed it and when was it agreed? The agreement took years to make and could all fall apart after Donald Trump withdrew the US from the deal - here's what you need to know 10th May 2018 [...] Which world powers signed it? Islamic Republic of Iran China France Russia United Kingdom United States of America Germany The European Union [...] https://www.thesun.co.uk/news/6184688/iran-nuclear-deal-world-powers-donald-trump-us-withdraws/ [no comments yet]
with all parties, including Iran, complying with the deal until Trump put this country in violation of the agreement
that bit you referenced at most a distinction without a difference (the next steps for any noncompliance with the deal never intended or expected to be by means of any court actions in any event), and absolutely meaningless in terms of whether the deal actually exists/existed or is/was a deal -- my comment stands
Trump wants foreign countries to pay more for U.S. drugs
By Modern Healthcare | May 10, 2018
President Donald Trump on Friday is expected to suggest using trade negotiations to convince foreign countries to increase what they pay for prescription drugs made in the U.S., according to sources.
Trump previously has said that lower prices paid in Canada, South Korea and a number of European countries devalue the research and development costs of producing new therapies in the U.S. He said the payment practice was akin to "global freeloading."
In a report earlier this year, the White House Council of Economic Advisers stated that profit margins on brand-name drugs in the U.S. were four times higher than those in some major European countries. The report said that South Korea, under a request by the White House, has agreed to pay higher prices for some drugs made in the U.S.
HHS Secretary Alex Azar in a speech this week hinted at the administration's move, saying that foreign governments were "free-riding" off the high costs that drugmakers set in the U.S.
Azar also pointed the finger at pharmacy benefit managers, which he said profit from rebates paid by drug companies that ask for their products to be favored in formularies. Those rebates aren't passed on to the consumer, Azar said.
Food and Drug Administration Commissioner Dr. Scott Gottlieb last week said tweaking the law that protects these rebates could be key to lowering prices.
"What if we took on this system directly, by having the federal government re-examine the current safe harbor for drug rebates?" Gottlieb asked.
Trump is expected to present his speech at 1 p.m. EDT on Friday.
News 
Market Data 
Discover 
/cdn.vox-cdn.com/uploads/chorus_image/image/59658215/471374298.jpg.0.jpg)
